JCR Pharmaceuticals Co.,Ltd.
4552 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 芦屋市春日町３番１９号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
JCR Pharmaceuticals Co., Ltd. is a prominent Japanese biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies. With a strong focus on addressing unmet medical needs, JCR specializes in the development of biotechnology products, particularly in the areas of rare diseases and regenerative medicine. The company's commitment to excellence is reflected in its rigorous adherence to global standards, ensuring the safety and efficacy of its offerings. JCR Pharmaceuticals aims to expand its global presence while fostering partnerships that enhance healthcare outcomes worldwide. Through its pioneering work, JCR continues to contribute significantly to the advancement of medical science and patient care.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 02:00 |
Inside Information Statement
臨時報告書
|
Japanese | 23.8 KB | |
| 2025-06-25 08:38 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-06-25 08:37 |
Internal Control over Financial Reporting
内部統制報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 25.8 KB | |
| 2025-06-25 08:36 |
Annual Report
有価証券報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 1.7 MB | |
| 2024-11-14 03:16 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-11-14 03:15 |
Interim Report
半期報告書－第50期(2024/04/01－2025/03/31)
|
Japanese | 219.6 KB | |
| 2024-07-23 09:30 |
Inside Information Statement
臨時報告書
|
Japanese | 28.5 KB | |
| 2024-06-28 02:00 |
Inside Information Statement
臨時報告書
|
Japanese | 26.0 KB | |
| 2024-06-26 07:12 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2024-06-26 07:11 |
Internal Control over Financial Reporting
内部統制報告書－第49期(2023/04/01－2024/03/31)
|
Japanese | 23.5 KB | |
| 2024-06-26 07:07 |
Annual Report
有価証券報告書－第49期(2023/04/01－2024/03/31)
|
Japanese | 1.7 MB | |
| 2024-02-14 03:07 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-02-14 03:06 |
Quarterly Report
四半期報告書－第49期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 169.6 KB | |
| 2024-01-19 03:04 |
Regulatory News Service
訂正確認書
|
Japanese | 8.3 KB | |
| 2024-01-19 03:03 |
Regulatory News Service
訂正有価証券報告書－第48期(2022/04/01－2023/03/31)
|
Japanese | 874.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |